October 24, 2011 – Cancer experts from around the world gathered in Berlin to hear about advances in radiotherapy that are bringing additional treatment possibilities for cancer patients. More than 450 oncologists, physicists and radiotherapy practitioners are at the two-day Berlin Oncology Summit, organized by Varian Medical Systems, to share experiences and highlight the expanding use of radiotherapy and radiosurgery to treat an increasingly wide range of cancers.

October 24, 2011 – Virtual Radiologic (vRad), a technology-enabled national radiology practice, has announced a premier radiology partnership with Icon Medical Imaging, the medical imaging division of Icon.

October 24, 2011 – As a result of the long-standing relationship between Philips Healthcare and ScImage Inc., the two companies are pleased to announce a newly developed integration option between ScImage’s PicomEnterprise picture archive and communications systems (PACS) and the Philips PageWriter TC series cardiographs. As a team, the two companies believe this interface will greatly simplify clinical electrocardiogram (ECG) workflow and reduce the complexity normally associated with custom integration.

 

October 24, 2011 – The European Association of Echocardiography (EAE) has announced that it is working together with the American Society of Echocardiography (ASE) to issue joint recommendations on the usefulness of serial echocardiographic evaluations and the potential impact of more advanced ultrasound technologies (in particular speckle tracking echocardiography) in patients undergoing cancer therapy.

 

Reverse Curve Soft Touch Transducer

October 21, 2011 — At RSNA 2011, U-Systems will showcase its new Reverse Curve Soft Touch Transducer technology. The system was designed and optimized for use with the U-Systems’ somo•v Automated Breast Ultrasound (ABUS) system.

October 21, 2011 — The National Institute of Cancer (INCan) is the first to offer positron emission mammography (PEM) to the residents of Mexico. PEM is the breast application of the Naviscan high-resolution positron emission tomography (PET) scanner that shows the location as well as the metabolic phase of a lesion. It is the only U.S. Food and Drug Administration (FDA)-cleared 3-D molecular breast imaging (MBI) device on the market.

October 21, 2011 — When we think about breast cancer, most of us think of it as a disease only affecting women. The truth is, about 2,140 new cases of invasive breast cancer will be diagnosed among men this year, according to the American Cancer Society.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now